The 23rd Congress of the Venezuelan Association of Endocrinologists and Nutritionists was held on September 15–18 in Caracas. GEROPHARM was the first Russian company to participate in the event.
The company’s experts raised issues of social significance of diabetes mellitus, talked about the history of its treatment and modern insulin products, including those produced by GEROPHARM. Particular attention was paid to the need to form a national registry of diabetic patients and the value of this tool for healthcare professionals and specialised research centres.
The experts were also invited to a regular meeting of doctors with representatives of the patient community, where they spoke about the characteristics of diabetes and therapy, as well as about the insulin products available in Venezuela since 2019. This contributed to their better understanding of the patients’ needs and concerns.